Inositol polyphosphate 5-phosphatases act on inositol phosphates and phosphoinositides as substrates.
They are 10 different isoenzymes and several splice variants in the human genome that are involved in a series of
human pathologies such as the Lowe syndrome, the Joubert and MORM syndromes, breast cancer, glioblastoma,
gastric cancer and several other type of cancers. Inositol 5-phosphatases can be amplified in human cancer cells,
whereas the 3- and 4- phosphatase tumor suppressor PTEN and INPP4B, repectively are often repressed or deleted.
The inositol 5-phosphatases are critically involved in a complex network of higly regulated phosphoinositides,
affecting the lipid content of PI(3, 4, 5)P3, PI(4, 5)P2 and PI(3, 4)P2. This has an impact on the normal behavior of
many intracellular target proteins e.g. protein kinase B (PKB/Akt) or actin binding proteins and final biological
responses. The production of PI(3, 4P)2 by dephosphorylation of the substrate PI(3, 4, 5)P3 is particularly important
as it produces a new signal messenger in the control of cell migration, invasion and endocytosis. New inhibitors/activators of inositol 5-
phosphatases have recently been identified for the possible control of their activity in several human pathologies such as inflamation and